Is antibiotic prophylaxis in breast augmentation necessary? A prospective study.

Area of Science:

• Plastic Surgery
• Surgical Infections
• Antibiotic Prophylaxis

Background:

• The use of prophylactic antibiotics in breast augmentation surgery is a debated topic among surgeons.
• Despite controversy, many surgeons routinely administer antibiotics to patients undergoing breast augmentation.

Purpose of the Study:

• To evaluate the influence of prophylactic antibiotic use on the incidence of infection and capsular contracture after breast augmentation.
• To compare outcomes between patients receiving antibiotics and those who did not.

Main Methods:

• A prospective study involving 180 patients undergoing primary bilateral breast augmentation.
• Patients were divided into two groups: one received no antibiotics, the other received a single dose of intravenous cephalosporin.
• Outcomes including infection, hematoma, and capsular contracture were monitored over a one-year follow-up period.

Main Results:

• No significant differences in demographic or operative data were observed between the groups.
• No implant infections were reported in either group; one wound infection in the non-antibiotic group was successfully treated.
• No cases of capsular contracture or hematoma were reported in any patients.

Conclusions:

• The study suggests that prophylactic antibiotics may not significantly affect infection or capsular contracture rates in breast augmentation.
• The sample size was insufficient for definitive conclusions.
• Further randomized clinical trials and guidelines from aesthetic plastic surgery societies are recommended.